Artizan Biosciences
PrivateLast Round
Series A
Extension
Mar 1, 2021
Total Funding Raised
$23M
Company Overview
Artizan Biosciences operates in Healthcare & Life Sciences and is based in New Haven, Connecticut. Its latest recorded funding round was a Series A Extension round in March 2021.
Artizan Biosciences is a biotechnology company that develops microbiome-targeted precision medicines to treat inflammatory, autoimmune, and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Artizan Biosciences Comparables
Compare Artizan Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Piton Therapeutics | 86% | |
| Microbiotica | 81% | |
| MRM Health | 79% |
For institutional investors. Book with your work email.
Artizan Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 1, 2021 | ||||
| Series A | Jun 10, 2019 |
For institutional investors. Book with your work email.
Artizan Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A Extension |
| Hatteras Venture Partners | Series A, Series A Extension |
| Osage University Partners | Series A Extension, Series A |
| Elm Street Ventures | Series A Extension, Series A |
| Johnson & Johnson Innovation – JJDC | Series A |
| Malin PLC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2021
$11M round led by Hatteras Venture Partners and Biohaven Ltd.
- Jun 10, 2019
$12M round with participation from Johnson & Johnson Innovation – JJDC.
For institutional investors. Book with your work email.
Artizan Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Artizan Biosciences's valuation, stock price, and market status.
Is Artizan Biosciences a public or private company?
Artizan Biosciences is a private company.
What is the current stock price of Artizan Biosciences?
Artizan Biosciences is a private company, so its shares have no public market price. Caplight tracks Artizan Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Artizan Biosciences worth (valuation)?
Valuation information for Artizan Biosciences is not publicly available.
Can I buy Artizan Biosciences stock?
Artizan Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Artizan Biosciences's last funding round?
Artizan Biosciences's most recent funding round was Series A Extension on March 1, 2021.
Who are the main investors in Artizan Biosciences?
Key investors in Artizan Biosciences include Hatteras Venture Partners.
Will Artizan Biosciences IPO soon?
No public IPO plans have been announced for Artizan Biosciences.
How can I track Artizan Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Artizan Biosciences's shares on secondary markets.